FDA announces recall of contaminated antibiotic - KSLA News 12 Shreveport, Louisiana News Weather & Sports

FDA announces recall of contaminated antibiotic

The FDA has annonced the recall of a lot of injectible antibiotic that contains mold.  (Source: AP/Andrew Harnik, File) The FDA has annonced the recall of a lot of injectible antibiotic that contains mold. (Source: AP/Andrew Harnik, File)

(RNN) - A pharmaceutical company has issued a recall of an injectable antibiotic that contains mold. The problem was discovered when a product complaint led to the discovery of a white, particulate matter floating in a flexible bag containing the drug.

AutoMedica Pharma LLC is recalling one lot of Linesolis Injection 600/300mL flexible bags that was distributed from May 15 through Aug. 14, 2017.

The use of a non-sterile injectable product can result in fatal infections in a broad array of patients, the FDA said in its recall notice. So far, Automedica has not received any reports of adverse events or identifiable safety concerns attributed to the recall, the release stated.

The oaxasolidinone-class antibacterial is used in adults and children for the treatment of bacterial infections including several types of pneumonia, foot infections related to diabetes and other causes; skin and skin structure lesions and other infections that are resistant to other antibiotics.

Consumers with questions about the recall can contact Autobindo Customer Service weekdays from 9 a.m. to 5 p.m. ET at 1-866-850-2876.

If you need help returning your product or have questions about the recall process, contact Inmar at 1-800-967-5952 weekdays from 8:30 a.m. to 5 p.m. ET.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Complete and submit the report Online.

 Call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Copyright 2017 Raycom News Network. All rights reserved.

  • Latest health & fitness newsLatest health & fitness newsMore>>

  • Opioid treatment gap in Medicare: methadone clinics

    Opioid treatment gap in Medicare: methadone clinics

    Tuesday, April 24 2018 3:56 AM EDT2018-04-24 07:56:13 GMT
    Tuesday, April 24 2018 10:39 AM EDT2018-04-24 14:39:56 GMT
    (AP Photo/Kevin D. Liles, File). FILE - In this March 7, 2017, file photo, the CEO of a methadone clinic holds a 35 mg liquid dose of methadone in Rossville, Ga. The drug is the oldest and most effective of approved medications used to treat opioid add...(AP Photo/Kevin D. Liles, File). FILE - In this March 7, 2017, file photo, the CEO of a methadone clinic holds a 35 mg liquid dose of methadone in Rossville, Ga. The drug is the oldest and most effective of approved medications used to treat opioid add...
    Opioid overdoses killed 1,354 Americans ages 65 and older in 2016, but Medicare doesn't cover the oldest proven treatment for opioid addiction: methadone.More >>
    Opioid overdoses killed 1,354 Americans ages 65 and older in 2016, but Medicare doesn't cover the oldest proven treatment for opioid addiction: methadone.More >>
  • UN health agency: Dengue vaccine shouldn't be used widely

    UN health agency: Dengue vaccine shouldn't be used widely

    Thursday, April 19 2018 10:56 AM EDT2018-04-19 14:56:41 GMT
    Monday, April 23 2018 5:58 PM EDT2018-04-23 21:58:07 GMT
    The World Health Organization says that the first-ever vaccine for dengue needs to be dealt with in "a much safer way" and mostly given to people previously infected with the disease.More >>
    The World Health Organization says that the first-ever vaccine for dengue needs to be dealt with in "a much safer way" and mostly given to people previously infected with the disease.More >>
  • US experts back marijuana-based drug for childhood seizures

    US experts back marijuana-based drug for childhood seizures

    Thursday, April 19 2018 12:02 PM EDT2018-04-19 16:02:09 GMT
    Monday, April 23 2018 1:07 PM EDT2018-04-23 17:07:05 GMT
    US panel says a medicine made from the marijuana plant should be approved to treat severe epileptic seizures in children. (Source: Pixabay)US panel says a medicine made from the marijuana plant should be approved to treat severe epileptic seizures in children. (Source: Pixabay)

    US panel says a medicine made from the marijuana plant should be approved to treat severe epileptic seizures in children.

    More >>

    US panel says a medicine made from the marijuana plant should be approved to treat severe epileptic seizures in children.

    More >>
Powered by Frankly